Concepedia

Publication | Open Access

Tocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series

24

Citations

36

References

2020

Year

Abstract

Tocilizumab could be an adjunct safe therapy in rapidly evolving COVID-19 pneumonia and associated critical illness.

References

YearCitations

Page 1